new inhaler, Seebri Breezhaler (glycopyrronium, SEA-bree), for patients with chronic obstructive pulmonary disease (COPD)

You'll see a new inhaler, Seebri Breezhaler (glycopyrronium, SEA-bree), for patients with chronic obstructive pulmonary disease (COPD).

Think of Seebri as similar to Spiriva (tiotropium). Both are dosed once daily...cost over $50/month...and work by keeping airways open to prevent wheezing, coughing, and other COPD symptoms.

Seebri even comes in capsule form for INHALATION, like Spiriva. Patients must remove the capsule from the blister pack...place it into the inhaler device...close the device to pierce the capsule...then breathe the med into their lungs through the inhaler.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote